FI20155779A - Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu - Google Patents
Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annosteluInfo
- Publication number
- FI20155779A FI20155779A FI20155779A FI20155779A FI20155779A FI 20155779 A FI20155779 A FI 20155779A FI 20155779 A FI20155779 A FI 20155779A FI 20155779 A FI20155779 A FI 20155779A FI 20155779 A FI20155779 A FI 20155779A
- Authority
- FI
- Finland
- Prior art keywords
- dosage
- steroidal anti
- delayed release
- inflammatory drug
- inflammatory
- Prior art date
Links
- 230000003111 delayed effect Effects 0.000 title 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 title 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/02—Polysilicates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
- C08L83/02—Polysilicates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Pain & Pain Management (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20155779A FI20155779A7 (fi) | 2015-10-30 | 2015-10-30 | Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu |
| CA3042345A CA3042345C (en) | 2015-10-30 | 2016-10-31 | Sustained-release non-steroidal anti-inflammatory drug delivery |
| AU2016345552A AU2016345552B2 (en) | 2015-10-30 | 2016-10-31 | Sustained-release non-steroidal anti-inflammatory drug delivery |
| ES16816319T ES2757299T3 (es) | 2015-10-30 | 2016-10-31 | Suministro de fármaco anti-inflamatorio no esteroideo de liberación sostenida |
| DK16816319T DK3368015T3 (da) | 2015-10-30 | 2016-10-31 | Levering af ikke-steroidt anti-inflammatorisk lægemiddel med vedvarende frigivelse |
| PCT/FI2016/050759 WO2017072415A1 (en) | 2015-10-30 | 2016-10-31 | Sustained-release non-steroidal anti-inflammatory drug delivery |
| US15/772,097 US10548843B2 (en) | 2015-10-30 | 2016-10-31 | Sustained-release silica composite depot non-steroidal anti-inflammatory drug delivery |
| EP16816319.4A EP3368015B1 (en) | 2015-10-30 | 2016-10-31 | Sustained-release non-steroidal anti-inflammatory drug delivery |
| JP2018541566A JP2018536704A (ja) | 2015-10-30 | 2016-10-31 | 徐放性非ステロイド性抗炎症性薬物送達 |
| NZ742382A NZ742382B2 (en) | 2016-10-31 | Sustained-release non-steroidal anti-inflammatory drug delivery | |
| PL16816319T PL3368015T3 (pl) | 2015-10-30 | 2016-10-31 | Dostarczanie niesteroidowego leku przeciwzapalnego o przedłużonym uwalnianiu |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20155779A FI20155779A7 (fi) | 2015-10-30 | 2015-10-30 | Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI20155779A true FI20155779A (fi) | 2017-05-01 |
| FI20155779A7 FI20155779A7 (fi) | 2017-05-01 |
Family
ID=57590534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI20155779A FI20155779A7 (fi) | 2015-10-30 | 2015-10-30 | Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10548843B2 (fi) |
| EP (1) | EP3368015B1 (fi) |
| JP (1) | JP2018536704A (fi) |
| AU (1) | AU2016345552B2 (fi) |
| CA (1) | CA3042345C (fi) |
| DK (1) | DK3368015T3 (fi) |
| ES (1) | ES2757299T3 (fi) |
| FI (1) | FI20155779A7 (fi) |
| PL (1) | PL3368015T3 (fi) |
| WO (1) | WO2017072415A1 (fi) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019050749A1 (en) * | 2017-09-08 | 2019-03-14 | Eli Lilly And Company | PHARMACEUTICAL COMBINATIONS COMPRISING INSULIN AND AT LEAST ONE AGENT SELECTED AMONG MELOXICAM, BROMFENAC SODIUM, ACETYLSALICYLIC ACID, SALICYLIC ACID AND PARACETAMOL |
| JP2023532778A (ja) * | 2020-07-07 | 2023-07-31 | デルシテック オサケユイチア | シリカハイドロゲルコンポジットおよびその使用 |
| US20220105029A1 (en) * | 2020-10-07 | 2022-04-07 | The Board Of Trustees Of The University Of Arkansas | Biodegradable chitosan microneedle patch for transdermal delivery for livestock pain management |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1251650B (it) | 1991-10-29 | 1995-05-17 | Boehringer Ingelheim Italia | Composti in incusione di meloxicam con ciclodestrine |
| WO1999009988A1 (en) | 1997-08-27 | 1999-03-04 | Hexal Ag | New pharmaceutical compositions of meloxicam with improved solubility and bioavailability |
| NZ513013A (en) | 1999-02-22 | 2002-11-26 | Bioxid Oy | Biodegradable ceramic fibres from silica sols useful in delivery devices for biologically active agents |
| AUPR602401A0 (en) * | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release delivery system |
| WO2008051537A2 (en) | 2006-10-20 | 2008-05-02 | Coin Acceptors, Inc. | A method of examining a coin for determining its validity and denomination |
| FI20070174A0 (fi) | 2007-02-28 | 2007-02-28 | Delsitech Oy | Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt |
| DE102008033327A1 (de) * | 2008-07-16 | 2010-01-21 | Bayer Innovation Gmbh | Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik |
| JP5316610B2 (ja) * | 2011-08-03 | 2013-10-16 | ダイキン工業株式会社 | 電気機器の制御装置および制御システム |
| US9533050B2 (en) | 2011-12-29 | 2017-01-03 | Laboratorios Andromaco S.A. | Vaginal ring including meloxicam and an agent for modulating the release of the active principle, which can be used as a continuous-use contraceptive in women |
| US9250674B2 (en) * | 2013-01-18 | 2016-02-02 | General Electric Company | Methods and systems for restoring power based on forecasted loads |
| HRP20200134T1 (hr) | 2013-06-24 | 2020-08-21 | Delsitech Oy | Silika hidrogel kompozit |
| US9362773B2 (en) * | 2013-06-28 | 2016-06-07 | Nokia Technologies Oy | Method and apparatus for determination of a non-charging operation |
| DK3134068T3 (da) * | 2014-04-21 | 2021-10-04 | Heron Therapeutics Inc | Langtidsvirkende polymerafgivelsessystemer |
-
2015
- 2015-10-30 FI FI20155779A patent/FI20155779A7/fi not_active Application Discontinuation
-
2016
- 2016-10-31 CA CA3042345A patent/CA3042345C/en active Active
- 2016-10-31 AU AU2016345552A patent/AU2016345552B2/en active Active
- 2016-10-31 DK DK16816319T patent/DK3368015T3/da active
- 2016-10-31 US US15/772,097 patent/US10548843B2/en active Active
- 2016-10-31 WO PCT/FI2016/050759 patent/WO2017072415A1/en not_active Ceased
- 2016-10-31 PL PL16816319T patent/PL3368015T3/pl unknown
- 2016-10-31 JP JP2018541566A patent/JP2018536704A/ja active Pending
- 2016-10-31 ES ES16816319T patent/ES2757299T3/es active Active
- 2016-10-31 EP EP16816319.4A patent/EP3368015B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3368015A1 (en) | 2018-09-05 |
| PL3368015T3 (pl) | 2020-02-28 |
| AU2016345552B2 (en) | 2022-04-14 |
| CA3042345C (en) | 2024-02-06 |
| US20180311165A1 (en) | 2018-11-01 |
| NZ742382A (en) | 2024-07-26 |
| US10548843B2 (en) | 2020-02-04 |
| WO2017072415A1 (en) | 2017-05-04 |
| ES2757299T3 (es) | 2020-04-28 |
| DK3368015T3 (da) | 2019-11-25 |
| EP3368015B1 (en) | 2019-08-28 |
| JP2018536704A (ja) | 2018-12-13 |
| FI20155779A7 (fi) | 2017-05-01 |
| CA3042345A1 (en) | 2017-05-04 |
| AU2016345552A1 (en) | 2018-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL301322I2 (nl) | Repotrectinib en/of farmaceutisch aanvaardbare zouten daarvan | |
| NL301217I2 (nl) | tirzepatide en farmaceutisch aanvaardbare zouten daarvan | |
| HUE047477T2 (hu) | Palbociclib szilárd dózisformái | |
| DK3244948T3 (da) | Bestemmelse af medikamentdosis | |
| DK3278803T3 (da) | Fast farmaceutisk doseringsform af PARP-inhibitor, og anvendelse af fast farmaceutisk doseringsform af PARP-inhibitor | |
| DK3383363T3 (da) | Topiske farmaceutiske formuleringer til behandling af inflammatorisk-relaterede tilstande | |
| DK3169328T3 (da) | Quinolinderivater til behandling af inflammationssygdomme | |
| DK3521282T3 (da) | Quinazolinderivater anvendt til behandling af hiv | |
| DK3157508T3 (da) | Fast oral doseringsform af lipofile forbindelser | |
| DK3212230T3 (da) | Dosering og indgivelse af ikke-fucosylerede anti-CD40-antistoffer | |
| DK3068392T5 (da) | Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til behandlingen af cftr-medierede sygdomme | |
| DK3237045T3 (da) | Indretning til indgivelse af lægemidler | |
| DK3116491T3 (da) | Farmaceutiske sammensætninger af terapeutisk aktive forbindelser | |
| DK3102213T3 (da) | Farmaceutiske sammensætninger til behandlingen af inflammatoriske lidelser | |
| DK4335517T3 (da) | Indgivelse og dosering af diaminofenothiaziner | |
| DK3204398T3 (da) | Fremgangsmåder til fraseparering af gemcitabin-phosphat diastereoisomerer | |
| DK3324948T3 (da) | Flerlagsmikropartikler til frigivelse af en farmaceutisk aktiv forbindelse i en flydende doseringsform | |
| LT3212237T (lt) | Metotreksato vaistinė forma | |
| DK3185867T3 (da) | Krystalliseringsfremgangsmåde af aripiprazolderivater i forlængede frigivelsesformuleringer til behandling af skizofreni | |
| HRP20181572T1 (hr) | Režim doziranja spoja fgf-18 | |
| DK3275452T3 (da) | Farmaceutisk sammensætning med silibinin | |
| IL258852A (en) | Sustained release formulations of local anesthetics | |
| DK3145497T3 (da) | Coatede kapsler med modificeret frigivelse | |
| DK3297619T3 (da) | Terapeutiske anvendelser af L-4-chlorkynurenin | |
| DK3145499T3 (da) | Coatede kapsler med modificeret frigivelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |